Latest Articles

FeNO Is a Clinically Useful Biomarker of Type 2 Inflammation in Pediatric Patients With Asthma

Implementing Beyfortus successfully

Saudi initiatives on Bronchiolitis Recommendations

The first choice of RSV prevention is Nirsevimab; alternatively, palivizumab is to be considered in case of unavailability of Nirsevimab.

Atherosclerotic Cardiovascular Disease Risk Assessment

Regulate LDL-C level for those undergoing coronary revascularization (Diabetic Patients)

Achievement of ESC/EAS LDL-C Treatment Goals After an ACS with Statin and Alirocumab

Clinical practice experience in patients with familial hypercholesterolemia (FH) from the Safeheart registry

Proprotein convertase subtilisin/kexin type 9 inhibitors for heterozygous familial hypercholesterolemia: A clinical practice experience from the Safeheart registry

Odyssey outcomes - total events results

Optimal use of LLT after ACS